HLN: Haleon Group P/S Multiple

Corporate company logo of Haleon Group (HLN)

High loyalty to established brands guarantees a steady customer inflow, as confirmed by the P/S chart for Haleon plc. The value of 2.70 indicates the level of this metric, correlating business value with revenue. Haleon plc dominates the OTC segment, leveraging its global leadership in consumer healthcare and the brand recognition of Sensodyne and Theraflu.

Haleon Group - HLN P/S Multiple (period 04/28/2023 - 11/15/2026)

Metric breakdowns and analytics for Haleon (HLN)

- share price and consensus valuation forecast:
Price Performance Chart Haleon|HLN - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Haleon|HLN - Total Company Value
- balance sheet equity data:
Net Assets per Single Share Haleon|HLN - Book Capitalization|Market-to-Book Ratio haleon.com|HLN - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Debt to Capital Haleon plc|HLN - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Haleon|HLN - Company Total Debt|Debt to Net Assets Ratio Haleon|HLN - Company Long-Term Debt|Current Liabilities Haleon|Quick Liquidity haleon.com
- financial results and valuation multiples details:
HLN - Net Profit|Future Profit Haleon plc|HLN - P/E Multiple|Future Price to Earnings Multiple Haleon Corp|HLN - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Haleon|HLN - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Haleon|HLN - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months haleon.com|HLN - Earnings growth in current year|Expected earnings per share trend next year Haleon plc
- issuer revenue and sales details:
HLN - Revenue and Sales Volume|Projected Sales Volume Haleon PLC|HLN - Price-to-Revenue Ratio|Forward Price to Sales Haleon
Summary company analytics:Haleon PLC, HLN
Mass-produced product of haleon.com

The P/S ratio compares the market value of Haleon plc (HLN) to its sales volume, making it possible to determine the extent of overpayment for the business relative to the generated cash flow. By analyzing the price-to-sales ratio, an investor can timely recognize price overheating, which is critical for capital preservation when investing in a global consumer healthcare leader with high consumer loyalty.

Competitors of Haleon plc

KVUE (Kenvue Inc) - Market Capitalization-to-Revenue Ratio|Verona Pharma Corp - Market Cap to Revenue|Market Cap to Sales Volume MENS (Jyong Biotech Ltd)|ligand.com - P/S Multiple|amneal.com (AMRX) - Market Cap to Revenue|Perrigo (PRGO) - Price-to-Revenue Ratio|ALVO (Alvotech S.A.) - Price-to-Revenue Ratio|Market Cap to Revenue LQDA|P/S Multiple Galapagos Corp|Price-to-Revenue Ratio ANI Pharma (ANIP)|P/S Multiple MannKind Corporation (MNKD)|Price-to-Revenue Ratio Amphastar Pharmaceuticals Inc AMPH|P/S Multiple Pacira PCRX|ARS Pharmaceuticals Inc - P/S Multiple|TBPH - P/S Multiple|AQST (Aquestive Therapeutics) - Market Cap to Revenue|scPharmaceuticals, Inc. (SCPH) - P/S Multiple|Market Cap to Revenue TECX|P/S Multiple Tonix Pharma|Market Cap to Revenue SXTC (SXT Pharmaceuticals)|EPRX: Price-to-Sales Ratio|BioHarvest Sciences - Market Cap to Revenue|EXOZ: Market Cap to Revenue Ratio|ORMP - Price-to-Revenue Ratio|ENTX: Price-to-Revenue Ratio|HYFT: P/S Multiple|Market Cap to Revenue ABVC BioPharma Inc|CPIX (Cumberland Corp) - P/S Multiple|P/S Multiple quantumbiopharma.com|P/S Multiple FGEN|Market Cap to Revenue Telomir Pharmaceuticals, Inc. TELO|P/S Multiple RANI (Rani Therapeutics)|SNYR (Synergy CHC Corp) - Price-to-Sales Ratio|RLYB: Market Cap to Revenue|lexariabioscience.com (LEXX) - Market Cap to Revenue|Pulmatrix Inc (PULM) - Price-to-Revenue Ratio|PTHL: Market Cap to Sales Volume|APM (Aptorum Group Ltd) - P/S Multiple|Lyra Therapeutics Inc (LYRA) - Price-to-Revenue Coefficient|P/S Multiple IBO|Market Cap to Sales Volume TNFA|cbdMD, Inc. - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio PRFX|Altamira Therapeutics Ltd. - P/S Multiple|LIPO: Price-to-Revenue Ratio|OPTN: P/S Multiple|Price-to-Sales Ratio PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - P/S Multiple|PTPI (Petros Pharmaceuticals Inc) - Market Cap to Sales Volume|P/S Multiple QLI|SLRN - Price to Sales|P/S Multiple TFFP (TFF Pharmaceuticals, Inc)